Funding Agency

Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM057199-003
Application #
2300819
Study Section
Project Start
1994-12-01
Project End
1999-11-30
Budget Start
1995-12-11
Budget End
1996-05-31
Support Year
Fiscal Year
1995
Total Cost
Indirect Cost

  Institution

Name
University of Maryland Baltimore
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
003255213
City
Baltimore
State
MD
Country
United States
Zip Code
21201

  Publications

Egorin, M J; Zuhowski, E G; Rosen, D M et al. (2001) Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1. Cancer Chemother Pharmacol 47:291-302
Egorin, M J; Zuhowski, E G; Sentz, D L et al. (1999) Plasma pharmacokinetics and tissue distribution in CD2F1 mice of Pc4 (NSC 676418), a silicone phthalocyanine photodynamic sensitizing agent. Cancer Chemother Pharmacol 44:283-94
Egorin, M J; Rosen, D M; Wolff, J H et al. (1998) Metabolism of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) by murine and human hepatic preparations. Cancer Res 58:2385-96
Egorin, M J; Rosen, D M; Benjamin, S E et al. (1997) In vitro metabolism by mouse and human liver preparations of halomon, an antitumor halogenated monoterpene. Cancer Chemother Pharmacol 41:9-14